Noticias de SNY_US
Noticias del mercado
Últimas noticias sobre SNY_US — 310 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Biopharma bites: Sarclisa's delayed review, Lilly exits Rigel pact, Amneal's biosimilar buy and more from Sanofi, Ipsen
Sanofi (SNY) Receives FDA Approval for Dupixent in Young Patients
Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
Sanofi Q1 2026 earnings preview
Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision
Sanofi's Tzield approved in USA for children
Sanofi provides update on Sarclisa in the United States
Sanofi (SNY) Gains FDA Approval for Tzield to Treat Young Diabetes Patients
FDA approves Sanofi’s Tzield for children as young as one year
FDA expands Sanofi’s Tzield use to children as young as 1 for type 1 diabetes delay (SNY:NASDAQ)
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US
Página 12 de 16
